Performance Evaluation of Montelukast Pediatric Formulations: Part II — a PBPK Modelling Approach
Crossref DOI link: https://doi.org/10.1208/s12248-021-00662-1
Published Online: 2022-01-10
Published Print: 2022-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Guimarães, Mariana
Vertzoni, Maria
Fotaki, Nikoletta http://orcid.org/0000-0003-1826-7363
Text and Data Mining valid from 2022-01-01
Version of Record valid from 2022-01-10
Article History
Received: 22 June 2021
Accepted: 18 October 2021
First Online: 10 January 2022
Declarations
:
: The authors declare no competing interests.